SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein

Por um escritor misterioso
Last updated 07 novembro 2024
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
Abstract Pilomatricomas are benign tumors originating from the capillary matrix, which may
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
EPIGENETICS OF SKIN AGING
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
Multiple pilomatricomas by the numbers
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome, Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome,
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromas, BMC Medicine
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
Landmark Discoveries and Recent Advances in Type IV Pilus Research
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
SciELO - Brasil - New proteasome inhibitors in the treatment of multiple myeloma New proteasome inhibitors in the treatment of multiple myeloma
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
Population pharmacokinetics and exposure–response of selumetinib and its N‐desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas
SciELO - Brasil - Multiple pilomatricomas in twins with Rubinstein
Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial)

© 2014-2024 faktorgumruk.com. All rights reserved.